Overview

Imaging CRF X NOP Interactions in CUD

Status:
Recruiting
Trial end date:
2028-09-01
Target enrollment:
Participant gender:
Summary
This study uses [11C]NOP-1A positron emission tomography (PET) and a hydrocortisone challenge to image the interaction between nociceptive opioid peptide (NOP) receptors and cortisol/corticotrophin releasing factor (CRF) in subjects with cocaine use disorders (CUD) and matched healthy controls (HC). It will also examine whether alterations in CRF x NOP interactions predict relapse in subjects with CUD.
Phase:
Early Phase 1
Details
Lead Sponsor:
Rajesh Narendran
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone hemisuccinate